Navigation Links
Vaccine Reduces antibiotic-resistant infections in Children

Children who receive a vaccine to protect them against severe strains of the bacterium Streptococcus pneumoniae are less likely to contract a serious disease, according to a new study. //

Researchers from Harvard Medical School studied more than 740 children who lived in 16 diverse communities throughout Massachusetts. Results of the study show 28 percent of the children carried a strain of S. pneumoniae -- a bacterium that causes a person to become resistant to certain antibiotics and is responsible for nearly 80 percent of all serious infections.

More than 30 percent of the children were at least somewhat resistant to penicillin and trimethoprim; more than 20 percent were resistant to erythromycin; and 3 percent were resistant to clindamycin. Children who attended group childcare were four-times more likely to carry S. pneumoniae. Those who had recently used antibiotics or who had respiratory infections were also more likely to carry resistant strains of the bacterium.

Researchers say their study is the first of its kind to test for the bacterium after the introduction of a new vaccine that protects children from the seven most invasive strains of S. pneumoniae. The rate of children who carried an antibiotic resistant strain of the bacterium was the same in children who received the vaccine and in those who did not. However, children who received the vaccine were less likely to carry one of the seven more invasive strains. They also had a lower risk of contracting a serious disease.

Researchers say their study may not reflect the ultimate success of the vaccine because it was conducted only nine months after the vaccine was introduced. Researchers say "The use of this vaccine in combination with recently reported decreases in antibiotic prescribing are two important steps in protecting children from serious infections."
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads ... not found any of them to be very practical. She wanted to write a ... make changes in their health. It prompted her in writing “ A Clear Path ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/22/2017)... , ... April 22, 2017 , ... Ecommerce sales have ... States estimated to be $394.9 billion. The consequences of rapid innovation and growth ... the limits of technology, it is every business and individual’s job to give something ...
(Date:4/22/2017)... ... 2017 , ... The San Juan Capistrano summer camp team at the Boys and ... for summer camps to provide physical activities for all campers. To read the report, ... , With an increase in specialty camps that focus on what the report terms as ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology: